The global PARP Inhibitor Market is estimated to be valued at USD 6.60 billion in 2022 and is expected to exhibit a CAGR of 13.09% over the forecast period 2023-2031, as highlighted in a new report published by Coherent Market Insights.A) Market Overview:PARP inhibitors are a class of drugs that inhibit the activity of Poly (ADP-ribose) polymerase (PARP) enzymes in the body. These enzymes play...
English
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian